Nasonex Sinus
Therapy and medicine

Nasonex Sinus

Nasonex Sinus

Nasonex Sinus is a nasal spray in a metered bottle. Recommended for the treatment of sinusitis in adults and children, relieves swelling, facilitates nasal breathing. It is also used for the treatment and prevention of allergic rhinitis of seasonal manifestation or year-round.

Information

Indications for use (instruction): Nasonex Sinus

  • Treatment of seasonal or year-round allergic rhinitis in adults and children older than 2 years. Preventive treatment of allergic rhinitis of moderate and severe course is recommended to start 4 weeks before the expected start of the dusting season.
  • As an auxiliary therapeutic agent in the treatment of acute sinusitis with antibiotics in adults (including the elderly) and children over 12 years of age.
  • Treatment of symptoms of acute sinusitis without signs of severe bacterial infection in adults and children over 12 years of age.
  • Treatment of nasal polyps and related symptoms, including nasal congestion and loss of smell, in patients over the age of 18.

How to use

Before you start using a new bottle of the drug, you should calibrate it. Calibration is carried out by approximately 10 presses of the metering device, and a stereotypical delivery of the drug substance is established, at which approximately 100 mg of the suspension containing 50 μg of mometasone (one dose) is released with each press. If the nasal spray is not used for 14 days or longer, before the next use it is necessary to re-"spray" by 2 clicks until a full flow is observed. Do not pierce the nozzle before use.

Shake the vial vigorously before each use.

If the nozzle is clogged, you need to remove the plastic cap by gently pressing on the white ring, easily remove the nozzle and rinse it with warm running water, dry it and replace it. Do not try to clean the nozzle with a needle or other sharp object, as such actions will damage the dispenser.

Regular cleaning of the nozzle is very important.

Before each use, thoroughly clean the nose of mucus.

Treatment of seasonal or perennial allergic rhinitis: for adults (including the elderly) and children over 12 years of age, the recommended preventive and therapeutic dose of the drug is 2 injections (50 μg each) in each nostril 1 time per day (total daily dose – 200 μg) . After achieving the therapeutic effect for maintenance therapy, it is advisable to reduce the dose to 1 injection in each nostril 1 time per day (total daily dose – 100 mcg).

If the symptoms of the disease cannot be alleviated by using the drug in the recommended therapeutic dose, the daily dose can be increased to the maximum: 4 injections into each nostril once a day (total daily dose – 400 mcg). After the symptoms have subsided, a dose reduction is recommended.

The drug showed a clinically significant onset of action within 12 hours after the first use in some patients with seasonal allergic rhinitis. However, the full benefit of treatment cannot be obtained in the first 48 hours, therefore, the patient must continue regular use to achieve the full therapeutic effect.

For children 2–11 years of age, the recommended therapeutic dose is 1 injection (50 μg) in each nostril once a day (total daily dose is 100 μg).

Auxiliary treatment of acute sinusitis. For adults (including the elderly) and children over 12 years of age, the recommended therapeutic dose is 2 injections (50 μg) in each nostril 2 times a day (total daily dose – 400 μg).

If the symptoms of the disease cannot be alleviated by using the drug in the recommended therapeutic dose, the daily dose can be increased to 4 injections in each nostril 2 times a day (total daily dose – 800 mcg). After the symptoms have subsided, a dose reduction is recommended.

Acute rhinosinusitis. For adults and children over 12 years of age, the recommended therapeutic dose is 2 injections (50 μg) in each nostril 2 times a day (total daily dose – 400 μg).

Nasal polyps. For patients over 18 years of age (including the elderly), the recommended dose is 2 injections (50 μg) in each nostril 2 times a day (total daily dose – 400 μg). After achieving the clinical effect, it is recommended to reduce the dose to 2 injections in each nostril once a day (total daily dose – 200 mcg).

Contraindications

Hypersensitivity to the active substance or to any inactive component of the drug.

Composition

Active ingredient: 1 dose of spray contains mometasone furoate monohydrate (micronized) in an amount equivalent to 50 μg mometasone furoate (anhydrous).

Excipients: dispersed cellulose (microcrystalline cellulose and sodium carboxymethyl cellulose), glycerin, citric acid, monohydrate, sodium citrate, dihydrate; polysorbate-80; benzalkonium chloride solution, purified water.

Release form

10 g (60 doses) of suspension in a polyethylene bottle with a metering pump-sprayer, closed cap. 1 bottle in a cardboard box.

Storage conditions

Store at a temperature not exceeding 25 °C out of the reach of children. Do not freeze.

Manufacturer

Schering-Plough Labo N.V., Industrial Park 30 Heist-op-den-Berg, 2220, Belgium.

Sanitary and hygienic conclusion

No.2319 dated 11/21/2019.
Registration Certificate No. UA/11264/01/01.